Like EXINI Diagnostics

on offer 10/13/2015 via

Progenics Pharmaceuticals, offer to acquire EXINI Diagnostics

synopsis: Progenics Pharmaceuticals announced its offer to acquire EXINI Diagnostics, a leader in the development software solutions for medical decision support based on advanced image analysis. The deal provides Progenics with sophisticated software and other technologies that help physicians and patients visualize, understand, target and treat cancer.
buyer: Progenics Pharmaceuticals (PGNX:$43.27)
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer. "
target parent: Avanza Bank Holding
target: EXINI Diagnostics
EXINI develops and provides software for automated image analysis, increasing accuracy and improving clinical efficiency when treating prostate cancer and other diseases. Their image analysis technology combines the power of artificial neural networks, expert medical knowledge and large databases.
price ($mm)[EV]
$7.12 [$6.63]
rev ($mm)
$2
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 4/25/2022 via BNC Analysis

Coexya Group, acquired Aquilab SAS

synopsis: Coexya, independent leader in the digital sector as an integrator, software publisher and consulting firm, announces the acquisition of Aquilab, a publisher specializing in the health sector. Based in northern France, Aquilab has been a recognised software provider in the field of oncology for more than 20 years.
buyer: Coexya Group
Coexya is a French independent digital leader in consulting, integration and software development. Coexya covers six fields of expertise: Customer experience, content & modern workplace, health, legal, location intelligence and smart data. "
target: Aquilab SAS
Based in northern France, Aquilab has been a recognised software provider in the field of oncology for more than 20 years. Aquilab products include Artiscan, which ensures the quality of imaging and radiotherapy equipment, and Artiview, which improves the prep and evaluation of radiotherapy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/5/2019 via PR Newswire

Volpara Solutions, will acquire MRS Systems

synopsis: New Zealand-based Volpara, a provider of breast imaging analytics products for improving the early detection of breast cancer, will acquire MRS Systems, Inc. MRS provides comprehensive patient tracking, communication, and a radiology reporting platform for sub-specialty radiology applications including breast and lung imaging.
buyer: Volpara Solutions (ASX:VHT:$3.29)
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT. "
target: MRS Systems
MRS Systems, Inc. tracks and reports on breast and lung cancer screening and imaging reports, among others. Users interact with MRS's software to document patient history, risk factors, and the findings of advanced imaging of patients using X-rays, MRI, CT, Ultrasound and other modalities.
price ($mm)
$15
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/28/2020 via BusinessWire

Wenzel Spine, Inc., acquired Statera Spine, Inc.

synopsis: Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, has acquired Statera Spine, a pre-operative diagnostics and quantitative data software solution that improves treatment decisions for spine patients.
buyer: Wenzel Spine, Inc.
Wenzel Spine is a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders. Wenzel Spine is focused on delivering surgical solutions that improve the overall quality of spine care by simplifying procedures and reducing recovery time. "
target: Statera Spine, Inc.
Statera Spine is a software-enabled spine imaging analytics company providing solutions that improve care for patients with chronic and acute spine issues. The company offers two solutions for spinal treatment, Profile-ESP (Expanded Spine Parameters Report) and VMA (Vertebral Motion Analysis).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/28/2017 via GlobeNewswire

Medasys, acquired Netika SAS

synopsis: Medasys, a company that offers software solutions to the Patient Records, care provision, Biology and Medical Imaging departments of private and public sector healthcare institutions, has acquired Netika, a company that specializes in software for quality assurance and management of laboratory information systems.
buyer parent: Ardian
buyer: Medasys (ENXTPA:MED:$38.05)
Medasys has been supporting the performance, quality and innovation of private and public healthcare institutions for almost 30 years, providing them with proven solutions in the Patient Records, care provision, Biology and Medical Imaging departments. "
target: Netika SAS
Netika is a French IT services provider, based in Strasbourg, dedicated to the medical sector since 2000. With more than 2,200 health institutions that trust it, Netika is a key player for medical laboratories, but is opening to new medical domains such as medical imaging and radiotherapy.
price ($mm)
$11
rev ($mm)
$7
EBITDA ($mm)
$1
EV / rev
1.6x
EV / EBITDA
9.8x
announced 7/18/2017 via BNC Analysis

Philips Electronics NV, will acquire TomTec Imaging Systems GmbH

synopsis: Philips Electronics NV announced that it has signed an agreement to acquire TomTec Imaging Systems GmbH, a provider of intelligent image analysis software, especially for diagnostic ultrasound. Tomtec's products and services support clinicians to increase efficiency and diagnostic quality through automated and reproducible measurements.
buyer: Philips Electronics NV (ENXTAM:PHIA:$22,796.71)
Royal Philips of the Netherlands is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. "
target: TomTec Imaging Systems GmbH
Headquartered in Munich, Germany, TomTec Imaging Systems is a worldwide leader for medical image software solutions. Their products encompass a wide range of 2D and 3D/4D technology for visualization, automated analysis, quantification, reporting and image management.
price ($mm)
rev ($mm)
$11
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
announced 3/8/2017 via BusinessWire

Envision Healthcare Holdings, Inc., will acquire Imaging Advantage LLC

synopsis: Envision Healthcare has entered into a definitive agreement to acquire Imaging Advantage LLC, a provider of comprehensive radiology services including hospital-based, outpatient and remote-reading services. Imaging Advantage deploys an innovative and scalable cloud-based technology to optimize provider utilization and efficiency of radiologists.
buyer: Envision Healthcare Holdings, Inc. (EVHC:$3,696.00)
Envision Healthcare Corporation is a leading provider of physician-led services, ambulatory surgery services, post-acute care and medical transportation. Physician-led services encompass providers at more than 780 hospitals in 45 states. "
target: Imaging Advantage LLC
Imaging Advantage is a leading provider of evidence-based, end-to-end technology enhanced radiology solutions to hospitals across the country. Imaging Advantage provides technology and practice management solutions to a number of prominent healthcare systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2013 via Company Press Release

EMIS Group PLC, acquired Digital Healthcare Limited

synopsis: EMIS Group, the UK’s leading supplier of healthcare software to GPs and a major software supplier to high street pharmacies has acquired Digital Healthcare. Digital Healthcare's principal area of business is providing solutions and services to manage and support systematic population-based retinal screening programmes.
buyer: EMIS Group PLC (AIM:EMIS:$221.66)
Egton Medical Information Systems Ltd (EMIS) is the UK's market leading primary care software provider with more than 39 million patient records entrusted to its systems. Its aim is to make good quality, timely patient information available any time, any where through interoperable systems. "
target: Digital Healthcare Limited
Digital Healthcare Limited provides image management and storage solutions for the ophthalmology sector. The company’s products include OptoMize, a retinopathy screening solution; OcuLab, an ophthalmology image management system; and Retasure, a diabetic retinal risk assessment system.
price ($mm)
$4.75
rev ($mm)
$5
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 2/28/2013 via BNC Analysis

Novacyt Société Anonyme, acquired CCITI

synopsis: Novacyt acquired the assets of Centre of Competence in International Tele-imaging (CCITI), specializing in digital pathology. The integration of active CCITI and its software suite for digital pathology provide an additional service to the diagnostics software module developed by Novacyt cell recognition.
buyer: Novacyt Société Anonyme
Novacyt Société Anonyme develops and markets liquid-based cytology solutions. It provides liquid cytology vials and sedimentation systems; Novastic, a liquid to optimize adherence of cells onto the glass slide; and NovaPrep processor systems for mass screening and personalized diagnosis. "
target: CCITI
CCITI (international competency center in Télé Imaging) is a software editor and consultant for healthcare and Life sciences. They provide innovative solutions based on full web solutions, digital slides and multimedia imaging along with knowledge management tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/4/2012 via BNC Analysis

Jonas Software, acquired Kestral Computing Pty Ltd.

synopsis: Constellation Software Inc announced that its wholly-owned subsidiary, Gary Jonas Computing Ltd., has completed the acquisition of Kestral Computing Pty Ltd., a leading provider of software to the Radiology and Laboratory information systems industry in Australia, New Zealand and parts of Asia.
buyer parent: Constellation Software, Inc.
buyer: Jonas Software
Jonas Software is the leading provider of enterprise management software solutions to the Club, Foodservice, Construction, Leisure Fitness & Sports, Attractions, Metal Service Centers, Moving & Storage and Education industries. "
target: Kestral Computing Pty Ltd.
Kestral Computing provides software solutions to the Australian and New Zealand health industry. Kestral specialises in best of breed solutions for Radiology and Pathology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/23/2010 via Company Press Release

Ventana Medical Systems, Inc., acquired BioImagene

synopsis: Roche announced that it has signed an agreement under which Ventana Medical Systems Inc., a member of the Roche Group, will acquire 100 percent of BioImagene, Inc., a privately held company based in Sunnyvale, California. The purchase price is approximately 100 million US dollars on a debt-free basis.
buyer parent: Roche Ltd
buyer: Ventana Medical Systems, Inc.
Ventana develops, manufactures, and markets instrument/reagent systems that automate tissue preparation and slide staining in clinical histology and drug discovery laboratories worldwide. "
target: BioImagene
BioImagene provides sophisticated bio-image analysis products built on iHarness, its patent-pending technology platform. BioImagene's products allow physicians and researchers to analyze and interpret images with far greater speed and consistency.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/1/2009 via BusinessWire

BioClinica, Inc., acquired CardioNow, Inc.

synopsis: BioClinica, Inc., a global provider of clinical trial services, announced that it has acquired the CardioNow unit of Agfa HealthCare. With this addition, BioClinica now offers streamlined electronic transport solutions to facilitate the blinding, sharing, tracking and archiving of medical images for multi-center clinical trials.
buyer: BioClinica, Inc.
BioClinica is a global clinical trials service organization, providing medical image management and eClinical services. This includes electronic data capture and clinical data management solutions to pharmaceutical, biotechnology and medical device companies and other organizations. "
target parent: Agfa Corp.
target: CardioNow, Inc.
CardioNow is an Image Management Service (IMS) that stores cardiac images, and transmits these images to cardiologists over the Internet as needed. The company also provides management consulting services for cardiologists.
price ($mm)
$1.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/2/2007 via BusinessWire

Nuance Communications, Inc., acquired Commissure Inc.

synopsis: Nuance Communications, Inc., a leading supplier of speech and imaging solutions, has acquired Commissure Inc., a medical imaging software company that provides speech-enabled radiology workflow optimization and data analysis solutions.
buyer: Nuance Communications, Inc. (NUAN:$1,463.14)
Nuance is a leading provider of speech and imaging solutions for businesses and consumers around the world. Its technologies, applications and services make the user experience more compelling by transforming the way people interact with information and how they create, share and use documents. "
target: Commissure Inc.
Commissure Inc. is a medical imaging company creating convergence technologies to help healthcare professionals fully utilize their medical imaging IT infrastructure. Commissure solutions embrace existing products and standards, enhancing them with integration and application software.
price ($mm)[EV]
$24 [$24]
rev ($mm)
$0
EBITDA ($mm)
EV / rev
79.2x
EV / EBITDA
announced 3/21/2018 via BNC Analysis

Atrys Health, S.A., will acquire Telrads S.L.

synopsis: Atrys, a biomedical company in Spain that provides diagnostic services and medical treatments, will acquire Telrads, a teleradiology company in Spain that helps hospitals and clinics manage their diagnostic imaging services. Telrads provides the efficiency in workflow their client needs, from when the patient arrives to the delivery of the report.
buyer: Atrys Health, S.A. (BME:ATRY:$10.43)
Atrys is a biomedical company in Spain dedicated to providing diagnostic services and excellent medical treatments. Their aim is to facilitate patients with individualized therapy, as well as to develop new therapeutic modalities and diagnostic tools. "
target: Telrads S.L.
Telrads is a teleradiology company in Spain that helps hospitals and clinics manage their diagnostic imaging services. From when the patient arrives to the delivery of the report, Telrads ensures the highest quality of care, excellence in service, and efficiency in workflow that their client needs.
price ($mm)
$4.05
rev ($mm)
$2
EBITDA ($mm)
$1
EV / rev
2.7x
EV / EBITDA
7.6x
closed 10/18/2017 via Company Press Release

MNH Group, acquired NGI Group SAS

synopsis: Mutuelle Nationale des Hospitaliers (MNH Group), a leading health insurance company in France, has acquired a majority stake in the NGI Group, a leading provider of medical imaging technologies and radiology information systems in France. NGI's GXD5 PACS is a comprehensive suite for storing, archiving, networking and distributing medical images.
buyer: MNH Group
Mutuelle Nationale des Hospitaliers (MNH Group) is a leading health insurance company in France. MNH Group also offers auto and home insurance. "
target: NGI Group SAS
The NGI Group is a leading provider of medical imaging technologies and radiology information systems in France. Their GXD5 PACS (Picture Archiving and Communication System) is a comprehensive suite for storing, archiving, networking and distributing medical images.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2011 via BusinessWire

3DISC Imaging, acquired Coreware Co, Ltd.

synopsis: 3DISC Imaging, a manufacturer of high-quality, affordable medical imaging products, has acquired CoreWare, a longtime provider of digital radiography software. CoreWare offers a range of high-quality image processing software solutions for computed radiography, digital radiography, and PACS to its customers.
buyer: 3DISC Imaging
3DISC Imaging specializes in quality imaging products for the medical, dental, chiropractic, and veterinary markets. Its products are based on innovative concepts that provide highly productive, compact devices and software solutions that deliver uncompromising image quality. "
target: Coreware Co, Ltd.
CoreWare is a provider of digital radiography software. The company offers a range of high-quality image processing software solutions for computed radiography, digital radiography, and PACS to customers throughout Korea, as well as in other Asian countries and the United States.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/17/2022 via Company Press Release

Intelerad Medical Systems, Inc., acquired PenRad Technologies

synopsis: Intelerad Medical Systems™, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad Technologies, Inc., a software provider for enhancing productivity for breast imaging and lung screening. PenRad's products have a proven track record of eliminating overhead costs and increasing patient satisfaction.
buyer parent: HgCapital
buyer: Intelerad Medical Systems, Inc.
Intelerad is one of the leading providers of medical imaging software and services for the healthcare industry. Headquartered in Raleigh, NC and Montreal, nearly 2,000 healthcare organizations around the world rely on Intelerad products to manage patient data. "
target: PenRad Technologies
Founded in 1995, PenRad offers a total solution for breast imaging and Low Dose Computed Tomography (LDCT) lung screening, enhancing practice workflow. PenRad’s client/server SQL enterprise architecture supports all customers ranging from individual imaging facilities to enterprise systems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/25/2018 via BusinessWire

Intelerad Medical Systems, Inc., acquired Clario Medical Imaging, Inc.

synopsis: Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of Clario Medical, a zero footprint worklist company based in Seattle, Washington. The Clario Smart Worklist Platform is designed to increase radiologist productivity.
buyer: Intelerad Medical Systems, Inc.
Intelerad is a leader in enterprise workflows, specializing in diagnostic viewing, reporting, and collaboration solutions for hospitals, imaging centers and reading groups. They are headquartered in Montréal, Québec, Canada. "
target: Clario Medical Imaging, Inc.
The Clario Smart Worklist Platform is designed to increase radiologist productivity. Through worklist optimization and exam prioritization, radiologists are ensured they are reading the most important exams making radiologist day-to-day operations and patient care more productive and efficient.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2022 via GlobeNewswire

RadNet, Inc., acquired Aidence

synopsis: RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers, has acquired Aidence, a leading radiology AI company focusing on clinical solutions for pulmonary nodule management and lung cancer screening.
buyer: RadNet, Inc. (RDNT:$1,296.72)
RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. "
target: Aidence
Aidence Holding B.V. is a leading radiology artificial intelligence company focusing on clinical solutions for pulmonary nodule management and lung cancer screening.
price ($mm)
$40
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/16/2020 via Company Press Release

Intelerad Medical Systems, Inc., acquired Digisonics, Inc.

synopsis: Intelerad Medical Systems, a global leader in enterprise imaging workflow solutions, has acquired Digisonics, Inc., a provider of cardiovascular and obstetrics/gynecology information and structured reporting systems. Digisonics provides a web-based enterprise PACS and structured reporting solution that helps physicians to optimize their workflows.
buyer parent: HgCapital
buyer: Intelerad Medical Systems, Inc.
Montreal-based Intelerad is a medical imaging software provider that specialises in diagnostic viewing, reporting, and collaboration solutions. The company serves over 300 healthcare organizations around the world, with a strength in radiology groups, imaging centers, clinics, and reading groups. "
target: Digisonics, Inc.
Digisonics is a leading provider of cardiovascular and obstetrics/gynecology information and structured reporting systems. Digisonics provides a web-based enterprise PACS and structured reporting solution that helps physicians to optimize their workflows and improve patient care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
on offer 10/13/2015 via

Progenics Pharmaceuticals, offer to acquire EXINI Diagnostics

synopsis: Progenics Pharmaceuticals announced its offer to acquire EXINI Diagnostics, a leader in the development software solutions for medical decision support based on advanced image analysis. The deal provides Progenics with sophisticated software and other technologies that help physicians and patients visualize, understand, target and treat cancer.
buyer: Progenics Pharmaceuticals (PGNX:$43.27)
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer. "
target parent: Avanza Bank Holding
target: EXINI Diagnostics
EXINI develops and provides software for automated image analysis, increasing accuracy and improving clinical efficiency when treating prostate cancer and other diseases. Their image analysis technology combines the power of artificial neural networks, expert medical knowledge and large databases.
price ($mm)[EV]
$7.12 [$6.63]
rev ($mm)
$2
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
on offer 10/13/2015 via

Progenics Pharmaceuticals, offer to acquire EXINI Diagnostics

synopsis: Progenics Pharmaceuticals announced its offer to acquire EXINI Diagnostics, a leader in the development software solutions for medical decision support based on advanced image analysis. The deal provides Progenics with sophisticated software and other technologies that help physicians and patients visualize, understand, target and treat cancer.
buyer: Progenics Pharmaceuticals (PGNX:$43.27)
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer. "
target parent: Avanza Bank Holding
target: EXINI Diagnostics
EXINI develops and provides software for automated image analysis, increasing accuracy and improving clinical efficiency when treating prostate cancer and other diseases. Their image analysis technology combines the power of artificial neural networks, expert medical knowledge and large databases.
price ($mm)[EV]
$7.12 [$6.63]
rev ($mm)
$2
EBITDA ($mm)
EV / rev
3.0x
EV / EBITDA
closed 3/17/2022 via Company Press Release

EMIS Group, acquired FourteenFish Ltd

synopsis: EMIS Group, a British leader in clinical IT software for joined-up patient care, has acquired medical appraisals specialist FourteenFish. Based in the UK, FourteenFish supports over 100,000 healthcare professionals – including GPs, nurses and practice managers – with their continued professional development (CPD) and ongoing industry learning.
buyer: EMIS Group (AIM:EMIS:$221.66)
EMIS Group is a British leader in clinical IT software for joined-up patient care, supplying essential technology to 10,000 healthcare organisations across every major UK health sector. "
target: FourteenFish Ltd
FourteenFish Ltd is a UK-based company specialising in medical appraisals. FourteenFish supports over 100,000 healthcare professionals – including GPs, nurses and practice managers – with their continued professional development (CPD) and ongoing industry learning.
price ($mm)
$21
rev ($mm)
$3
EBITDA ($mm)
EV / rev
6.6x
EV / EBITDA
closed 7/20/2020 via BNC Analysis

Carepointe merged with US Health Systems,

synopsis: Carepointe, a healthcare technology company whose cloud-based payment systems focus on managed and value-based care, has merged with US Health Systems (USHS), a value-based population health management company. The merger of Carepointe and USHS will create Arkos Health, and they will operate as subsidiaries of the new company.
buyer: US Health Systems
US Health Systems (USHS) is a value-based population health management company. USHS processes often stop the complex cycle of patients returning to acute facilities or emergency rooms and allow the patient to remain or return to their medical home with primary care or advanced primary care. "
target parent: OnPointe
target: Carepointe
Carepointe technology solves the tough challenges of managing complex populations and integrating health service delivery. CarePointe's cloud-based payment systems focus on managed care and value-based care and have 2,500 providers across the country.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2019 via BusinessWire

Regroup Telehealth Inc. merged with InSight Telepsychiatry,

synopsis: InSight Telepsychiatry and Regroup Telehealth have merged to become the largest and most comprehensive telepsychiatry service provider in the US. The merger brings together a robust network of providers and a group of clinical and executive leaders with extensive experience and expertise for underserved individuals and communities.
buyer parent: Harbour Point Capital
buyer: InSight Telepsychiatry
InSight is the leading national telepsychiatry service provider increasing access to quality behavioral health care through applications of technology. InSight serves hundreds of organizations across the country with its on-demand, scheduled services, and Inpathy divisions. "
target: Regroup Telehealth Inc.
Regroup provides customized telepsychiatry solutions, technology, and support teams that contribute to the seamless integration of behavioral health clinicians at partner care sites. Their clinicians collaborate with onsite care teams on patient care plans and workflows for better behavioral care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/23/2019 via MSNBC

Amazon.com, Inc., acquired Health Navigator

synopsis: Amazon, a company that strives to be Earth's most customer-centric company where people can find and discover virtually anything they want to buy online, acquired Health Navigator, a company that provides evidence-based digital health information content that advances patient and provider experience.
buyer: Amazon.com, Inc. (AMZN:$469,822.00)
Amazon strives to be Earth's most customer-centric company where people can find and discover virtually anything they want to buy online. By giving customers more of what they want—low prices, vast selection, and convenience—Amazon continues to grow and evolve as a world-class e-commerce platform. "
target: Health Navigator
Health Navigator provides evidence-based digital health information content that advances patient and provider experience. It works with partners to provide tools that help with remote diagnoses, helping patients figure out whether to stay at home, see a doctor or go straight to the emergency room.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/7/2022 via BNC Analysis

PanGenomic Health Inc., will acquire Mindleap Health

synopsis: PanGenomic Health Inc., a digital health platform in Canada, will acquire Mindleap Health Inc. from Mydecine Innovations Group Inc., a biotechnology company. Mindleap is a telehealth solution that helps people connect with mental health specialists. The app helps people to sleep better, feel safe, and understand psychedelic experiences.
buyer: PanGenomic Health Inc. (CNSX:NARA:$0.00)
PanGenomic is a digital health platform in Canada. PanGenomic provides people with personal control over their mental health treatments. Their Nara solution is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. "
target parent: Mydecine
target: Mindleap Health
Mindleap is a telehealth solution that helps people connect with mental health specialists. Mindleap helps people to sleep better, feel safe, and understand psychedelic experiences. The app allows users to talk to specialists that break down information into useful and digestible segments.
price ($mm)
$3.08
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/9/2021 via GlobeNewswire

Patient Access Solutions, Inc., acquired Tela Mental Health

synopsis: Patient Access Solutions (PASO), a provider of healthcare/financial processing and management solutions for the healthcare industry, has acquired Tela Mental Health. This acquisition will allow PASO to offer mental health services through the telamentalhealth.com portal, connecting patients to psychologists, psychiatrists and therapists nationwide.
buyer parent: Global Energy Resources, Inc
buyer: Patient Access Solutions, Inc. (OTCPK:PASO:$1.82)
Patient Access Solutions Inc. is a Healthcare Solutions company with its sights set on shaking up a stodgy healthcare information technology industry. Paying little respect to tradition in a business rooted in tradition, PASHealth has created a formidable array of technologyand resources. "
target: Tela Mental Health
Tela Mental Health is an American healthcare institution, specializing in mental health. Tela Mental Health is focused on mental wellness for patients accessing their care provider remotely and the demand for this is high.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/20/2022 via PR Newswire

Quip NYC, Inc., acquired Toothpic App

synopsis: quip has acquired Toothpic, a leading telehealth company offering teledental services and care to more than 36 million Americans through partnerships with premier dental insurers. The acquisition makes quip the first oral care company to connect at-home oral care products with preventative telehealth services and professional dental care.
buyer: Quip NYC, Inc.
quip is a modern oral health company that provides thoughtfully designed personal oral care products and professional dental care services through a digital platform that makes oral care more simple, accessible, and enjoyable. "
target: Toothpic App
Toothpic is a leading smart dental technology company on a mission to radically transform people's oral health. Toothpic leverages technology, data and insights to deliver better care, better outcomes and a more personalized experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2020 via GlobeNewswire

CLARITAS HealthTech Pte. Ltd, acquired Integrated Health Ventures Pte Ltd

synopsis: Singapore-based Claritas HealthTech Pte. Ltd., is acquiring Integrated Health Ventures Pte Ltd (IHV) in Singapore and its company in India. IHV has an extensive network of hundreds of hospital and diagnostic center clients for their proprietary teleradiology platform in several developing regions including, South Asia and Africa.
buyer: CLARITAS HealthTech Pte. Ltd
Claritas is incorporated and headquartered in Singapore. Claritas conducts research and development in the fields of image enhancement, machine vision and artificial intelligence (“AI”) with a focus on medical image processing and AI assisted interpretation. "
target: Integrated Health Ventures Pte Ltd
IHV ("Integrated Health Ventures") is headquartered in Singapore, with a development center in Chennai, India. For over a decade, the company has provided teleradiology platforms with low bandwidth optimised and secure clinical systems for hundreds of hospitals and radiology centers globally.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2017 via BNC Analysis

Cannabis Sativa, Inc., acquired PrestoDoctor

synopsis: Cannabis Sativa. Inc., a company that develops and promotes natural cannabis products, has acquired a 51% stake in PrestoCorp (a.k.a. PrestoDoctor), an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology.
buyer: Cannabis Sativa, Inc. (OTCPK:CBDS:$0.03)
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. "
target: PrestoDoctor
PrestoDoctor is an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology. Appointments are 10-15 minutes long, and can be scheduled and completed in the same day.
price ($mm)
$2.39*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like EXINI Diagnostics


read more

EXINI Diagnostics

Aquilab SAS

MRS Systems

Statera Spine, Inc.

Netika SAS

TomTec Imaging Systems GmbH

Imaging Advantage LLC

Digital Healthcare Limited

CCITI

Kestral Computing Pty Ltd.

BioImagene

CardioNow, Inc.

Commissure Inc.

Telrads S.L.

NGI Group SAS

Coreware Co, Ltd.

PenRad Technologies

Clario Medical Imaging, Inc.

Aidence

Digisonics, Inc.

read more

EXINI Diagnostics

read more

EXINI Diagnostics

read more

FourteenFish Ltd

Carepointe

Regroup Telehealth Inc.

Health Navigator

Mindleap Health

Tela Mental Health

Toothpic App

Integrated Health Ventures Pte Ltd

PrestoDoctor

Geography
Matching Companies
Ticker: VAR
 
 
 
 
 
 
 
 
Varian Medical Systems, Inc.
Varian Medical Systems, Inc.
Varain Medical Systems produces tools that harness the power of X-ray energy to benefit humankind. They have made developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing.
year
2018
rev ($mm)
$2,888.20
EBITDA ($mm)
$597.60
EBIT ($mm)
$525.70
Net Income ($mm)
$143.20
Employees
6600
  • drill down
  • watch
Ticker: ASX:VHT
 
 
 
 
 
 
 
 
Volpara Solutions
Volpara Solutions
Volpara Health Technologies Limited (VHT) is a New Zealand MedTech Software as a Service company. VHT is a leading provider of breast imaging analytics products that improve clinical decision-making and the early detection of breast cancer. Volpara Solutions is the sales and marketing arm of VHT.
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
  • drill down
  • watch
Ticker: OB:CSAM
 
 
 
 
 
 
 
 
CSAM Health AS
CSAM Health AS
CSAM is a leading Norwegian company in the specialized eHealth market with a unique blend of best in class innovative technology, and outstanding human skills. Their diverse portfolio of software solutions enables healthcare providers to access relevant clinical information at the point of care.
year
2021
rev ($mm)
$34.31
EBITDA ($mm)
$3.97
EBIT ($mm)
($2.02)
Net Income ($mm)
Employees
282
  • drill down
  • watch
Ticker: NMXS
 
 
 
 
 
 
 
 
Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc.
Net Medical Xpress is a medical services company that provides clinical and diagnostic programs using advanced telemedicine solutions for hospitals. The company also develops FDA 510k-cleared and all-inclusive PACS products within the preventative, comprehensive, and critical healthcare segments.
year
2011
rev ($mm)
$3.21
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.21)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: ASX:RAP
 
 
 
 
 
 
 
 
ResApp Health
ResApp Health
ResApp Health is a mobile telehealth solution based in Australia. ResApp Health assists doctors and empowers patients to diagnose and manage respiratory disease. Their solution allows doctors to instantly diagnose respiratory diseases from the sound of their patient’s cough or breathing.
year
2021
rev ($mm)
$0.05
EBITDA ($mm)
($4.93)
EBIT ($mm)
($5.04)
Net Income ($mm)
Employees
510
  • drill down
  • watch
Ticker: OM:EKTA B
 
 
 
 
 
 
 
 
Elekta AB
Elekta AB
Elekta is pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops state-of-the-art tools and treatment-planning systems for radiation therapy, as well as workflow-enhancing software systems across the spectrum of cancer care.
year
2020
rev ($mm)
$1,523.59
EBITDA ($mm)
$230.61
EBIT ($mm)
$200.20
Net Income ($mm)
$125.79
Employees
4000
  • drill down
  • watch
Ticker: CM:CLRX
 
 
 
 
 
 
 
 
CollabRX, Inc
CollabRX, Inc
CollabRx, Inc. is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts.
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
  • drill down
  • watch
Ticker: ASX:VRI
 
 
 
 
 
 
 
 
Veriluma Limited
Veriluma Limited
Veriluma is an innovative Australian software company founded in 2010. Veriluma’s patented algorithm was originally developed for the Australian Department of Defence where situations can lack certainty and reliable information and may depend on input that is subjective.
year
2019
rev ($mm)
$0.58
EBITDA ($mm)
($0.24)
EBIT ($mm)
($0.24)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: KOSDAQ:A263700
 
 
 
 
 
 
 
 
Carelabs Co., Ltd.
Carelabs Co., Ltd.
Carelabs is a South Korea-based digital beauty and healthcare company. CareLabs provides comprehensive healthcare IT services, including clinic information services, clinic customer management software, and digital marketing solutions.
year
2019
rev ($mm)
$49.51
EBITDA ($mm)
$4.38
EBIT ($mm)
$3.14
Net Income ($mm)
$1.79
Employees
0
  • drill down
  • watch
Ticker: TSE:4543
 
 
 
 
 
 
 
 
Terumo Corporation
Terumo Corporation
Terumo is a global leader in medical technology. The company's business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems and diabetes care.
year
2020
rev ($mm)
$5,694.98
EBITDA ($mm)
$1,437.51
EBIT ($mm)
$927.04
Net Income ($mm)
$721.22
Employees
26438
  • drill down
  • watch
Ticker: CERN
 
 
 
 
 
 
 
 
Cerner Corporation
Cerner Corporation
Cerner's health information technologies connect people, information, and systems. Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations.
year
2021
rev ($mm)
$5,707.53
EBITDA ($mm)
$1,462.77
EBIT ($mm)
$1,008.36
Net Income ($mm)
$522.26
Employees
26400
  • drill down
  • watch
Ticker: 300253
 
 
 
 
 
 
 
 
Shanghai Kingstar Winning Software Co., Ltd.
Shanghai Kingstar Winning Software is principally engaged in the development of medical software, the provision of technology services and the distribution of hardware products. They primarily offer software, including hospital information systems and public health information management systems.
year
2015
rev ($mm)
$98.42
EBITDA ($mm)
$14.01
EBIT ($mm)
$12.72
Net Income ($mm)
$21.57
Employees
454
  • drill down
  • watch
Ticker: OM:RTC
 
 
 
 
 
 
 
 
Rethinking Care AB
Rethinking Care AB
Rethinking Care introduces a holistic concept in nursing & health, based on 3 interacting spheres of activity - "Software as a service", "Care as a service" & "Health as a service", based on a high level of competence in nursing & healthcare services as well as IT tools developed for health care.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: CPSI
 
 
 
 
 
 
 
 
CPSI
CPSI
CPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post-acute care facilities. Founded in 1979, CPSI is the parent of three companies – Evident, LLC, American HealthTech, Inc. and TruBridge, LLC.
year
2021
rev ($mm)
$262.74
EBITDA ($mm)
$33.37
EBIT ($mm)
$19.84
Net Income ($mm)
$14.30
Employees
2000
  • drill down
  • watch
Ticker: TSE:3902
 
 
 
 
 
 
 
 
Medical Data Vision Co., Ltd.
Medical Data Vision Co., Ltd.
Medical Data Vision (MDV) is a Japanese company that develops, produces, maintains, and sells medical information integration systems. Their solutions enable hospitals to easily view and compare detailed medical information from other hospitals.
year
2020
rev ($mm)
$39.30
EBITDA ($mm)
$10.42
EBIT ($mm)
$8.71
Net Income ($mm)
$5.96
Employees
226
  • drill down
  • watch
Ticker: PGNX
 
 
 
 
 
 
 
 
Progenics Pharmaceuticals
Progenics Pharmaceuticals
Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. They offer a first-in-class PSMA-targeted technology platform for prostate cancer.
year
2015
rev ($mm)
$43.27
EBITDA ($mm)
($0.54)
EBIT ($mm)
($1.07)
Net Income ($mm)
$2.85
Employees
57
  • drill down
  • watch
Ticker: ZTS
 
 
 
 
 
 
 
 
Zoetis
Zoetis
Zoetis is a global animal health company. Zoetis develops, manufactures and commercializes medicines, vaccines and diagnostic products. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals.
year
2019
rev ($mm)
$6,260.00
EBITDA ($mm)
$2,578.00
EBIT ($mm)
$2,193.00
Net Income ($mm)
$1,500.00
Employees
10600
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: PFE
 
 
 
 
 
 
 
 
Pfizer, Inc.
Pfizer, Inc.
Pfizer is the world's largest research-based biopharmaceutical company. Pfizer applies science and their global resources to deliver innovative therapies that improve lives. The company has a portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas.
year
2022
rev ($mm)
$81,288.00
EBITDA ($mm)
$30,793.00
EBIT ($mm)
$25,602.00
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: BSE:531637
 
 
 
 
 
 
 
 
Sword and Shield Pharma Ltd.
Sword and Shield Pharma Ltd.
Sword & Shield Pharma is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. They offer a portfolio of products including Active Pharmaceutical Ingredients, generics, differentiated formulations and News Chemical Entities.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: CNSX:NF
 
 
 
 
 
 
 
 
Mydecine
Mydecine
Mydecine is a biotechnology company. Mydecine is developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder. They aim to provide patients with safer and more effective treatment solutions.
year
2019
rev ($mm)
$0.18
EBITDA ($mm)
($3.31)
EBIT ($mm)
($3.35)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: EXAS
 
 
 
 
 
 
 
 
Exact Sciences
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. Exact Sciences develops diagnostic tests for several types of cancer. Its flagship product is Cologuard, a stool-based DNA test for colorectal cancer.
year
2017
rev ($mm)
$213.82
EBITDA ($mm)
($118.76)
EBIT ($mm)
($133.03)
Net Income ($mm)
Employees
736
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch